Georgia
Prescription drug spending and prescribing in Georgia, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $9.1B for prescriptions written in Georgia, the 10th most of 52 states and territories, and 4.3% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $9.1B
- Medicaid drugs, 2025: $1.3B
- Opioid share of claims: 4.3%
- Life-science raises, 2 years: $406M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Georgia | United States | Difference |
|---|---|---|---|
| Opioids | 4.3% | 3.5% | +22% |
| Antibiotics | 4.3% | 4.4% | -3% |
| Antipsychotics | 1.6% | 1.7% | -9% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Georgia's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Cyproheptadine Hcl | 2.8× | 19,929 |
| Colesevelam Hcl | 2.5× | 20,855 |
| Carisoprodol | 2.0× | 21,948 |
| Promethazine Hcl | 1.9× | 77,706 |
| Bisoprolol/Hydrochlorothiazide | 1.8× | 33,133 |
| Telmisartan/Hydrochlorothiazid | 1.7× | 13,295 |
| Oxycodone Hcl/Acetaminophen | 1.7× | 471,612 |
| Megestrol Acetate | 1.7× | 25,955 |
| Buprenorphine | 1.7× | 26,954 |
| Hydralazine Hcl | 1.6× | 316,081 |
Biggest Medicaid Drugs
What Georgia's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
44 Form D raises by companies based in Georgia in the last two years; the 10 largest. See all raises- BRIDGE TO LIFE LTD$83M · Other health care · Oct 21, 2026
- Altesa BioSciences, Inc.$75M · Pharma · Feb 23, 2026
- XO Health Inc.$52M · Other health care · Sep 4, 2025
- Airway Therapeutics, Inc.$43M · Biotech · Sep 9, 2026
- FEMASYS INC$30M · Biotech · Aug 20, 2026
- Panda Health, Inc.$18M · Other health care · Dec 26, 2024
- Micron Biomedical, Inc.$15M · Biotech · Dec 26, 2024
- Huxley Medical, Inc.$11M · Other health care · Sep 30, 2026
- Huxley Medical, Inc.$10M · Other health care · Nov 26, 2025
- Focused Cryo, Inc$9M · Other health care · Apr 23, 2026
State Attorney General Health-Care Cases
Antitrust cases Georgia joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Federal Trade Commission and State of Georgia v. Phoebe Putney Health System, Inc.,No. 1:11-cv-00058-WLS (M.D. Ga. Apr. 20, 2011)2011 · Pending
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)2003 · Settled
- Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL…2002 · Settled
- In the Matter of GlaxoSmithKline, PLC (Augmentin)Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG